Meridian Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $315K | Buy |
707
+87
| +14% | +$38.7K | 0.01% | 547 |
|
|
2025
Q1 | $301K | Buy |
620
+1
| +0.2% | +$485 | 0.01% | 520 |
|
|
2024
Q4 | $249K | Buy |
619
+14
| +2% | +$5.64K | 0.01% | 557 |
|
|
2024
Q3 | $281K | Buy |
605
+19
| +3% | +$8.84K | 0.01% | 533 |
|
|
2024
Q2 | $275K | Buy |
+586
| New | +$275K | 0.03% | 246 |
|
|
2024
Q1 | – | Sell |
-794
| Closed | -$323K | – | 558 |
|
|
2023
Q4 | $323K | Buy |
794
+31
| +4% | +$12.6K | 0.02% | 487 |
|
|
2023
Q3 | $265K | Sell |
763
-19
| -2% | -$6.61K | 0.02% | 470 |
|
|
2023
Q2 | $275K | Buy |
782
+1
| +0.1% | +$352 | 0.02% | 457 |
|
|
2023
Q1 | $246K | Sell |
781
-29
| -4% | -$9.14K | 0.02% | 470 |
|
|
2022
Q4 | $234K | Buy |
810
+25
| +3% | +$7.22K | 0.02% | 462 |
|
|
2022
Q3 | $227K | Sell |
785
-165
| -17% | -$47.7K | 0.02% | 430 |
|
|
2022
Q2 | $268K | Buy |
+950
| New | +$268K | 0.02% | 455 |
|
|
2021
Q1 | – | Sell |
-3,319
| Closed | -$784K | – | 377 |
|
|
2020
Q4 | $784K | Sell |
3,319
-338
| -9% | -$79.8K | 0.12% | 141 |
|
|
2020
Q3 | $995K | Buy |
3,657
+131
| +4% | +$35.6K | 0.24% | 83 |
|
|
2020
Q2 | $1.02M | Buy |
3,526
+145
| +4% | +$42.1K | 0.34% | 66 |
|
|
2020
Q1 | $804K | Buy |
+3,381
| New | +$804K | 0.36% | 60 |
|
|
2019
Q3 | – | Sell |
-140
| Closed | -$257 | – | 496 |
|
|
2019
Q2 | $257 | Buy |
+140
| New | +$257 | 0.01% | 495 |
|